Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.91% | 1.58% | |||
| Total Other Revenue | 3.25% | 3.44% | |||
| Total Revenue | -1.90% | 1.88% | |||
| Cost of Revenue | -0.20% | 3.91% | |||
| Gross Profit | -7.06% | -3.82% | |||
| SG&A Expenses | 0.95% | 3.52% | |||
| Depreciation & Amortization | 1.23% | 10.20% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.06% | 3.84% | |||
| Operating Income | -56.40% | -33.27% | |||
| Income Before Tax | -84.71% | -38.66% | |||
| Income Tax Expenses | -251.14% | -60.04% | |||
| Earnings from Continuing Operations | -54.00% | -31.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -50.00% | 300.00% | |||
| Net Income | -53.99% | -31.78% | |||
| EBIT | -56.40% | -33.27% | |||
| EBITDA | -45.34% | -28.84% | |||
| EPS Basic | -53.68% | -31.20% | |||
| Normalized Basic EPS | -71.38% | -37.95% | |||
| EPS Diluted | -53.64% | -31.09% | |||
| Normalized Diluted EPS | -71.33% | -37.90% | |||
| Average Basic Shares Outstanding | -0.67% | -0.84% | |||
| Average Diluted Shares Outstanding | -0.85% | -0.93% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.15% | 0.45% | |||